Stereotactic radiation therapy in oligometastatic colorectal cancer: outcome of 102 patients and 150 lesions.

Adult Aged Aged, 80 and over Colorectal Neoplasms / mortality Female Humans Male Middle Aged Neoplasm Metastasis Radiosurgery / adverse effects Radiotherapy Dosage Retrospective Studies
Colorectal adenocarcinoma Colorectal cancer Oligometastasis Radiation therapy Stereotactic

Journal

Clinical & experimental metastasis
ISSN: 1573-7276
Titre abrégé: Clin Exp Metastasis
Pays: Netherlands
ID NLM: 8409970

Informations de publication

Date de publication:
08 2019
Historique:
received: 03 01 2019
accepted: 29 05 2019
pubmed: 6 6 2019
medline: 24 3 2020
entrez: 6 6 2019
Statut: ppublish

Résumé

To evaluate the local control (LC), progression free survival (PFS), out-field PFS, overall survival (OS), toxicity and failure predictors of SRT in a series of various sites oligometastatic CRC patients. Patients with oligometastatic CRC disease were analyzed retrospectively. The SRT prescribed dose was dependent on the lesion volume and its location. 102 consecutive oligometastatic CRC patients (150 lesions) were included. They underwent SRT between 2012 and 2015. Median prescription dose was 45 Gy (median dose/fraction was 15 Gy/3 fractions biological equivalent dose (BED

Identifiants

DOI: 10.1007/s10585-019-09976-z PMID: 31165360
pubmed: 31165360
doi: 10.1007/s10585-019-09976-z
pii: 10.1007/s10585-019-09976-z
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

331-342

Références

Ann Surg. 2005 May;241(5):715-22, discussion 722-4
pubmed: 15849507
Ann Surg Oncol. 2005 Nov;12(11):900-9
pubmed: 16184442
Semin Radiat Oncol. 2006 Apr;16(2):77-84
pubmed: 16564443
Ann Oncol. 2006 Sep;17(9):1399-403
pubmed: 16873427
Acta Oncol. 2006;45(7):823-30
pubmed: 16982546
Radiother Oncol. 2006 Dec;81(3):264-8
pubmed: 17113668
Semin Radiat Oncol. 2008 Oct;18(4):215-22
pubmed: 18725106
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
J Clin Oncol. 2009 Apr 1;27(10):1585-91
pubmed: 19255313
J Clin Oncol. 2009 Apr 1;27(10):1579-84
pubmed: 19255320
J Clin Oncol. 2009 Apr 10;27(11):1829-35
pubmed: 19273699
Colorectal Dis. 2010 Jul;12(7 Online):e68-75
pubmed: 19843115
Br J Cancer. 2010 Apr 27;102(9):1313-8
pubmed: 20424612
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):889-97
pubmed: 21277113
Nat Rev Clin Oncol. 2011 Jun;8(6):378-82
pubmed: 21423255
Cancer. 2011 Sep 1;117(17):4060-9
pubmed: 21432842
World J Gastroenterol. 2012 Jan 7;18(1):25-33
pubmed: 22228967
Lancet Oncol. 2012 Apr;13(4):395-402
pubmed: 22285199
J Surg Oncol. 2012 Aug 1;106(2):138-43
pubmed: 22297789
J Thorac Oncol. 2012 Jul;7(7):1148-54
pubmed: 22610256
Clin Oncol (R Coll Radiol). 2012 Nov;24(9):629-39
pubmed: 22633542
Oncologist. 2012;17(8):1100-7
pubmed: 22723509
Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):336-42
pubmed: 23433800
Semin Intervent Radiol. 2013 Mar;30(1):49-55
pubmed: 24436517
Strahlenther Onkol. 2014 Oct;190(10):872-81
pubmed: 25091267
BMC Cancer. 2014 Aug 27;14:619
pubmed: 25163798
Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):837-42
pubmed: 25838188
Am J Clin Oncol. 2018 Jan;41(1):53-58
pubmed: 26270442
Clin Cancer Res. 2015 Dec 1;21(23):5198-204
pubmed: 26626571
Int J Radiat Oncol Biol Phys. 2016 Aug 1;95(5):1399-1404
pubmed: 27319288
Ecancermedicalscience. 2016 Sep 29;10:677
pubmed: 27729942
Radiat Oncol. 2017 Feb 1;12(1):35
pubmed: 28143558
Clin Genitourin Cancer. 2017 Aug;15(4):e623-e632
pubmed: 28185875
BJU Int. 2017 Nov;120(5):623-630
pubmed: 28188682
J Cancer Res Clin Oncol. 2017 Jul;143(7):1293-1299
pubmed: 28258344
Radiother Oncol. 2017 May;123(2):227-233
pubmed: 28274491
J Natl Cancer Inst. 2017 Sep 1;109(9):
pubmed: 28376151
Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):876-883
pubmed: 29063852
Med Phys. 2018 Apr;45(4):1360-1368
pubmed: 29431863
BMC Cancer. 2018 Mar 13;18(1):283
pubmed: 29534687
Tumori. 2018 Mar 1;:300891618765541
pubmed: 29714653
Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):650-660
pubmed: 29893277
J Radiosurg SBRT. 2018;5(3):217-227
pubmed: 29988326
Crit Rev Oncol Hematol. 2018 Sep;129:91-101
pubmed: 30097241

Auteurs

V Dell'Acqua (V)

Division of Radiotherapy, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.

A Surgo (A)

Division of Radiotherapy, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.

F Kraja (F)

Division of Oncology, University Hospital Centre "Mother Theresa", Rruga e Dibrës 372, 1000, Tirana, Albania.

J Kobiela (J)

Department of General, Endocrine and Transplant Surgery, Medical University of Gdansk, Marii Skłodowskiej-Curie 3a, 80-210, Gdańsk, Poland.

Maria Alessia Zerella (MA)

Division of Radiotherapy, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy. mariaalessia.zerella@ieo.it.
Department of Oncology and Hemato-Oncology, University of Milan, Via Festa del Perdono 7, 20122, Milan, Italy. mariaalessia.zerella@ieo.it.
ORCID: 0000-0002-0992-9022

P Spychalski (P)

Department of General, Endocrine and Transplant Surgery, Medical University of Gdansk, Marii Skłodowskiej-Curie 3a, 80-210, Gdańsk, Poland.

S Gandini (S)

Group Leader Department of Experimental Oncology, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.

C M Francia (CM)

Palliative Care and Pain Therapy Unit, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.

D Ciardo (D)

Division of Radiotherapy, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.

C Fodor (C)

Division of Radiotherapy, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.

A M Ferrari (AM)

Division of Radiotherapy, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.

G Piperno (G)

Division of Radiotherapy, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.

F Cattani (F)

Unit of Medical Physics, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.

S Vigorito (S)

Unit of Medical Physics, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.

F Pansini (F)

Unit of Medical Physics, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.

W Petz (W)

Division of Gastrointestinal Surgery, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy.

R Orecchia (R)

Scientific Directorate, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.

M C Leonardi (MC)

Division of Radiotherapy, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.

B A Jereczek-Fossa (BA)

Division of Radiotherapy, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, Via Festa del Perdono 7, 20122, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Stereotactic radiation therapy in...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Stereotactic radiation therapy in...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Sujet âgé de 80 ans ou plus › Stereotactic radiation therapy in...
questionsmedicales.fr › Maladies de l'appareil digestif › Maladies gastro-intestinales › Maladies intestinales › Maladies du rectum › Tumeurs colorectales › Stereotactic radiation therapy in...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Stereotactic radiation therapy in...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Stereotactic radiation therapy in...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Processus néoplasiques › Métastase tumorale › Stereotactic radiation therapy in...
questionsmedicales.fr › Techniques d'investigation › Techniques stéréotaxiques › Radiochirurgie › Stereotactic radiation therapy in...
questionsmedicales.fr › Thérapeutique › Radiothérapie › Dosimétrie en radiothérapie › Stereotactic radiation therapy in...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › Stereotactic radiation therapy in...